HDAC — Drug Target
All drugs that target HDAC — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- SHR2554; Chidamide analog tablets · Jiangsu HengRui Medicine Co., Ltd. · HDAC inhibitor · Oncology
Chidamide analog SHR2554 is an inhibitor of histone deacetylases (HDACs), which play a role in regulating gene expression.